Santhera Pharmaceuticals Holding AG (0QN1.L) Stock Price

CHF14.22 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    4

  • Fundamental

    3

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Santhera Pharmaceuticals Holding AG, AI stock picks, stock alerts and much more.

Sign up

0QN1.L AI Stock Analysis

AI stock analysis for 0QN1.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Santhera Pharmaceuticals Holding AG (0QN1.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Santhera Pharmaceuticals Holding AG (0QN1.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Santhera Pharmaceuticals Holding AG (0QN1.L), currently trading at CHF14.22, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0QN1.L

LSE

  • Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally.

  • Symbol

    0QN1.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    137.2M

Similar Stocks

0LTI.L Waters Corporation
0LTI.L		 $322.5
2.6%
6
0QZU.L Vertex Pharmaceuticals Incorporated
0QZU.L		 $490.2
0%
5
0K6R.L Neurocrine Biosciences
0K6R.L		 $100.6
1.7%
7
0IGA.L Emergent BioSolutions Inc.
0IGA.L		 $4.66
2.4%
4
0H7R.L Abeona Therapeutics Inc.
0H7R.L		 $4.91
1.4%
4

News

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Sees Significant Increase in Short Interest

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Sees Significant Increase in Short Interest
March 14, 2025. ETF Daily News

0QN1.L Alternative Data

Web Traffic

Santhera Pharmaceuticals Holding AG receives an estimated 5316 monthly visitors to santhera.com.

  • Web Traffic

    5316

  • Change from Previous Month

    113.5%

  • 3 Month Change

    17%

  • YoY Change

    17%

News Mentions

Santhera Pharmaceuticals Holding AG was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Santhera Pharmaceuticals Holding AG has 764 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.

  • Twitter Followers

    764

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.3%

Facebook Engagement

Santhera Pharmaceuticals Holding AG has engaged 1 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Instagram Followers

Santhera Pharmaceuticals Holding AG has 798 Instagram Followers on its main Instagram account.

  • Instagram Followers

    798

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    2%

Youtube Subscribers

Santhera Pharmaceuticals Holding AG has 36 subscribers on its main Youtube channel.

  • Youtube Subscribers

    36

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

19,547 are following Santhera Pharmaceuticals Holding AG on LinkedIn, up by 1.9% over the last month.

  • LinkedIn Followers

    19547

  • Daily Change

    0%

  • 1 Month Change

    1.9%

  • 3 Month Change

    6.1%

Reddit Mentions

Santhera Pharmaceuticals Holding AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

LinkedIn Employees

According to LinkedIn, Santhera Pharmaceuticals Holding AG has 101 employees.

  • LinkedIn Employees

    101

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    7.4%

0QN1.L Financials

0QN1.L Key Metrics

  • Total Revenue

    CHF7.1M

  • Net Income

    -CHF7.6M

  • Earnings per Share

    -CHF0.67

  • Free cash flow

    -CHF7.7M

  • EBITDA

    -CHF7.5M

  • EBITDA Ratio

    -1.06051

  • Total Assets

    CHF108.2M

0QN1.L 2-year Revenue & Income
0QN1.L 2-year Free Cash Flow

0QN1.L Technicals

0QN1.L SMA
0QN1.L RSI

FAQ

What's the current price of Santhera Pharmaceuticals Holding AG (0QN1.L) Stock?
The price of an Santhera Pharmaceuticals Holding AG (0QN1.L) share is CHF14.22.

What's the market cap of Santhera Pharmaceuticals Holding AG?
The current market cap of Santhera Pharmaceuticals Holding AG is 137.2M.

Should I buy or sell 0QN1.L?
Santhera Pharmaceuticals Holding AG shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Santhera Pharmaceuticals Holding AG is better viewed as a hold or accumulate position while waiting for further developments.

Is Santhera Pharmaceuticals Holding AG a good investment?
The current analysis of Santhera Pharmaceuticals Holding AG's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Santhera Pharmaceuticals Holding AG's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Santhera Pharmaceuticals Holding AG (0QN1.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Santhera Pharmaceuticals Holding AG stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Santhera Pharmaceuticals Holding AG (0QN1.L) that investors often compare it to?
Santhera Pharmaceuticals Holding AG (0QN1.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc. and Abeona Therapeutics Inc..

What is the forecast for Santhera Pharmaceuticals Holding AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Santhera Pharmaceuticals Holding AG's stock price to be around CHF13.82 in 2026. Starting from the current price of CHF14.22, this represents a 2.8% change in price, indicating a neutral outlook for the stock.

How to buy Santhera Pharmaceuticals Holding AG (0QN1.L) Stock?
Santhera Pharmaceuticals Holding AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Santhera Pharmaceuticals Holding AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.